Search Results - "Lhoest, N"

Is the duration of dual antiplatelet therapy (DAPT) excessive in post-angioplasty in chronic coronary syndrome? Data from the France-PCI registry (2014-2019) by Mezier, A, Motreff, P, Clerc, J M, Bar, O, Deballon, R, Demicheli, T, Dechery, T, Souteyrand, G, Py, A, Lhoest, N, Lhermusier, T, Honton, B, Gommeaux, A, Jeanneteau, J, Deharo, P, Benamer, H, Cayla, G, Koning, R, Pereira, B, Collet, J P, Rangé, G

“…while the duration of dual antiplatelet therapy (DAPT) following coronary angioplasty for chronic coronary syndrome (CCS) recommended by the European Society…”
Get full text

Outcome Impact of Coronary Revascularization Strategy Reclassification With Fractional Flow Reserve at Time of Diagnostic Angiography: Insights From a Large French Multicenter Fractional Flow Reserve Registry by Van Belle, Eric, Rioufol, Gilles, Pouillot, Christophe, Cuisset, Thomas, Bougrini, Karim, Teiger, Emmanuel, Champagne, Stéphane, Belle, Loic, Barreau, Didier, Hanssen, Michel, Besnard, Cyril, Dauphin, Raphael, Dallongeville, Jean, El Hahi, Yassine, Sideris, Georgios, Bretelle, Christophe, Lhoest, Nicolas, Barnay, Pierre, Leborgne, Laurent, Dupouy, Patrick

“…BACKGROUND—There is no large report of the impact of fractional flow reserve (FFR) on the reclassification of the coronary revascularization strategy on…”
Get full text

Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI: Results of the GIANT Study by Hulot, Jean-Sébastien, Chevalier, Bernard, Belle, Loic, Cayla, Guillaume, Khalife, Khalife, Funck, François, Berthier, Romain, Piot, Christophe, Tafflet, Muriel, Montalescot, Gilles

“…The aim of this study was to evaluate prospectively the clinical impact of routine transmission of CYP2C19 genotype in the management of acute ST-segment…”
Get full text

Impact of Routine Fractional Flow Reserve on Management Decision and 1-Year Clinical Outcome of Patients With Acute Coronary Syndromes: PRIME-FFR (Insights From the POST-IT [Portuguese Study on the Evaluation of FFR-Guided Treatment of Coronary Disease] and R3F [French FFR Registry] Integrated Multicenter Registries - Implementation of FFR [Fractional Flow Reserve] in Routine Practice) by Van Belle, Eric, Baptista, Sergio-Bravo, Raposo, Luís, Henderson, John, Rioufol, Gilles, Santos, Lino, Pouillot, Christophe, Ramos, Ruben, Cuisset, Thomas, Calé, Rita, Teiger, Emmanuel, Jorge, Elisabete, Belle, Loic, Machado, Carina, Barreau, Didier, Costa, Marco, Hanssen, Michel, Oliveira, Eduardo, Besnard, Cyril, Costa, João, Dallongeville, Jean, Pipa, João, Sideris, Georgios, Fonseca, Nuno, Bretelle, Christophe, Guardado, Jorge, Lhoest, Nicolas, Silva, Bruno, Barnay, Pierre, Sousa, Maria-João, Leborgne, Laurent, Silva, João Carlos, Vincent, Flavien, Rodrigues, Alberto, Seca, Luís, Fernandes, Renato, Dupouy, Patrick

“…BACKGROUND—Fractional flow reserve (FFR) is not firmly established as a guide to treatment in patients with acute coronary syndromes (ACS). Primary goals were…”
Get full text

Routine CYP2C19 Genotyping to Adjust Thienopyridine Treatment After Primary PCI for STEMI by Hulot, Jean-Sébastien, Chevalier, Bernard, Belle, Loic, Cayla, Guillaume, Khalife, Khalife, Funck, François, Berthier, Romain, Piot, Christophe, Tafflet, Muriel, Montalescot, Gilles, Chevalier, Bernard, Montalescot, Gilles, Hulot, Jean-Sébastien, Belle, Loïc, Cayla, Guillaume, Le Breton, Hervé, Teiger, Emmanuel, Dambrin, Grégoire, Khalife, K., Schmutz, L., Funck, F., Berthier, R., Piot, C., Hannebicque, G., Montalescot, G., Lognone, T., De Poli, F., Chevalier, B., Lhoest, N., Schneeberger, M., Delarche, N., Faure, A., Aelion, H., Godin, M., Gilard, M., Ritz, B., Barraud, P., Barnay, P., Saïdi, L.N., Le Dref, O., Garot, P., Range, G., Georges, J., Robin, C., Cottin, Y., Belle, L., Souteyrand, G., Lafont, A., Fournier, A., Dupouy, P., Shayne, J., Chapon, P., Boureux, C., Faure, J.P., Ben Amer, H., Furber, A., Ormezzano, O., Bayet, G., Karrillon, G., Maillard, L., Grenzinger, A., Avran, A., Koning, R., Dumant, D., Lamit, X., Dauphin, R., Drogoul, L., Cuisset, T., Wittenberg, O., Peyre, J.P., Laury, P., Robert, R.

“…The aim of this study was to evaluate prospectively the clinical impact of routine transmission of CYP2C19 genotype in the management of acute ST-segment…”
Get full text